Home › Funds › Cormorant Asset Management, LP › ORKA

Cormorant Asset Management, LP position in ORKA

ORUKA THERAPEUTICS INC · Health Care

Cormorant Asset Management, LP reported holding 533,340 shares of ORKA (ORUKA THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$50.8M, representing 2.60% of its reported portfolio and ranking #14 among its reported holdings. Cormorant Asset Management, LP has disclosed ORKA holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

Latest position (Q2 2026)533.34K sh
Reported value held$50.76M
Portfolio Weight2.60%
First reportedQ3 2025
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Cormorant Asset Management, LP's ORKA position evolved

Cormorant Asset Management, LP first disclosed a stake in ORKA in Q3 2025 at 533,340 shares (US$10.3M). The position peaked in Q2 2026 at 533,340 shares, worth US$50.8M. Across 4 filings, Cormorant Asset Management, LP held the position steady without any share-count change. The most recent filing (Q2 2026) shows 533,340 shares valued at US$50.8M.

Quarter by quarter

QuarterSharesValueChange
Q3 2025 533.34K $10.26M New
Q4 2025 533.34K $16.17M Hold
Q1 2026 533.34K $26.16M Hold
Q2 2026 533.34K $50.76M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ORKA and 13F data

ORKA (ORUKA THERAPEUTICS INC) is a Health Care company. 98 other funds we track also report a position in ORKA — the largest reported positions include Venrock Adviser, LLC (US$394.8M), Fairmount Funds Management LLC (US$352.6M), RTW INVESTMENTS, LP (US$298.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ORKA

All ORKA fund holders →

FAQ

How long has Cormorant Asset Management, LP held ORKA?

Cormorant Asset Management, LP has disclosed ORKA holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

What is Cormorant Asset Management, LP's current position in ORKA?

As of Q2 2026, Cormorant Asset Management, LP holds 533.34K shares of ORKA (ORUKA THERAPEUTICS INC), valued at $50.76M, representing 2.60% of its reported portfolio and ranking #14.

Has Cormorant Asset Management, LP been buying or selling ORKA?

In the latest 13F filing (Q2 2026), Cormorant Asset Management, LP held unchanged its position in ORKA. The position peaked in Q2 2026 at 533.34K shares.

Which other funds hold ORKA?

Other major institutional holders of ORKA include Venrock Adviser, LLC, Fairmount Funds Management LLC, RTW INVESTMENTS, LP, among 98 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.